Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (ILMN)
NASDAQ:ILMN
Holding ILMN?
Track your performance easily
ILMN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$89.00 - $148.19
Previous Close$130.21
Volume2.22M
Average Volume (3M)2.38M
Market Cap
$20.74B
Enterprise Value$23.52B
Total Cash (Recent Filing)$74.00M
Total Debt (Recent Filing)$2.85B
Price to Earnings (P/E)―
Beta1.54
Next Earnings
Oct 31, 2024EPS Estimate
$0.87Last Dividend Ex-Date
Jun 25, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-19.17
Shares Outstanding159,300,000
10 Day Avg. Volume1,437,258
30 Day Avg. Volume2,376,320
Standard Deviation0.12
R-Squared0.26
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)14.38
Price to Sales (P/S)4.65
Price to Cash Flow (P/CF)64.30
P/FCF Ratio105.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.31
Enterprise Value/Gross Profit8.57
Enterprise Value/Ebitda-12.42
Forecast
1Y Price Target
$149.06Price Target Upside13.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
Illumina News
Bulls Say, Bears Say
Bulls Say
Cost EfficiencyCost-saving initiatives could drive a meaningful EPS increase and $200 million in cost cuts, along with a 500bps EBIT margin expansion.
InnovationWith the pending introductions of 5-base genome and comprehensive WGS, the company can start repricing by workflow and application area, enhancing its product offerings.
LegalFavorable ECJ ruling removes prospect of EU fine, saving the company €432 million ($477 million).
Bears Say
Competitive ThreatCompetition poses real threats on both the high-throughput and medium-throughput sides of the business, potentially eating into ILMN’s upside potential.
Financial PerformanceThe company hasn’t grown at its targeted mid-teens revenue growth rate since 2021, and the topline CAGR over the past 3 years is approximately -1%.
Revenue GrowthIllumina appears unlikely to return to material revenue growth in 2025, as it leverages a multi-faceted strategy to reaccelerate.
---
Ownership Overview
1.87% Insiders
34.57% Mutual Funds
57.74% Other Institutional Investors
5.81% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ILMN FAQ
What was Illumina’s price range in the past 12 months?
Illumina lowest stock price was $89.00 and its highest was $148.19 in the past 12 months.
What is Illumina’s market cap?
Currently, no data Available
When is Illumina’s upcoming earnings report date?
Illumina’s upcoming earnings report date is Oct 31, 2024 which is in 42 days.
How were Illumina’s earnings last quarter?
Illumina released its earnings results on Aug 06, 2024. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.25.
Is Illumina overvalued?
According to Wall Street analysts Illumina’s price is currently Undervalued.
Does Illumina pay dividends?
Illumina pays a Notavailable dividend of $3.1 which represents an annual dividend yield of N/A. See more information on Illumina dividends here
What is Illumina’s EPS estimate?
Illumina’s EPS estimate is $0.87.
How many shares outstanding does Illumina have?
Illumina has 159,300,000 shares outstanding.
What happened to Illumina’s price movement after its last earnings report?
Illumina reported an EPS of $0.36 in its last earnings report, beating expectations of $0.11. Following the earnings report the stock price went up 4.074%.
Which hedge fund is a major shareholder of Illumina?
Among the largest hedge funds holding Illumina’s share is PRIMECAP Management Co. It holds Illumina’s shares valued at 254M.
---
Illumina Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$149.06 (13.81% Upside)
$149.06 (13.81% Upside)
Blogger Sentiment
Bullish
ILMN Sentiment 82%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.32%
12-Months-Change
Fundamentals
Return on Equity
-76.19%
Trailing 12-Months
Asset Growth
-48.35%
Trailing 12-Months
Company Description
Illumina
Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.
---
ILMN Company Deck
---
ILMN Earnings Call
Q2 2024
0:00 / 0:00
---
ILMN Revenue Breakdown
68.45% Consumables
15.92% Service and other revenue
15.63% Instruments
---
ILMN Stock 12 Month Forecast
Average Price Target
$149.06
▲(13.81% Upside)
Technical Analysis
Best Analysts Covering ILMN
1 Year
1 Year Success Rate
24/30 ratings generated profit
1 Year Average Return
+17.93%
reiterated a buy rating 4 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +17.93% per trade.
---